Nerve cells could transform the treatment of Parkinson’s
By tove [dot] smeds [at] med [dot] lu [dot] se (Tove Smeds) - published 22 December 2022 At the end of October 2022, the Swedish Medical Products Agency gave the go-ahead for a clinical trial of the stem cell-based therapy STEM-PD for the treatment of Parkinson’s disease. The cells, generated from embryonic stem cells, have been in development for several years and will now be transplanted into pa
https://www.lunduniversity.lu.se/article/nerve-cells-could-transform-treatment-parkinsons - 2024-12-24